Viewing StudyNCT00419081



Ignite Creation Date: 2024-05-05 @ 5:14 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00419081
Status: TERMINATED
Last Update Posted: 2012-01-23
First Post: 2007-01-05

Brief Title: Study of Forodesine Hydrochloride in Patients With RelapsedRefractory Precursor T-Lymphoblastic LeukemiaLymphoma Who Have Failed Two or More Prior Treatment Regimens
Sponsor: BioCryst Pharmaceuticals
Organization: BioCryst Pharmaceuticals

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-07
Start Date Type: None
Primary Completion Date: 2007-03
Primary Completion Date Type: ACTUAL
Completion Date: 2007-03
Completion Date Type: ACTUAL
First Submit Date: 2007-01-05
First Submit QC Date: January 5 2007
Study First Post Date: 2007-01-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2012-01-18
Disp First Submit QC Date: January 18 2012
Disp First Post Date: 2012-01-23
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2012-01-18
Last Update Post Date: 2012-01-23
Last Update Post Date Type: ESTIMATED